Arovella Therapeutics Limited (ASX:ALA) Raises $20M to Fund Phase 1 Clinical Trials
Arovella Therapeutics (ASX:ALA) secures $20 million placement, fully funding Phase 1 trials for ALA-101 and advancing its cancer therapy pipeline.
Arovella Therapeutics (ASX:ALA) secures $20 million placement, fully funding Phase 1 trials for ALA-101 and advancing its cancer therapy pipeline.
Blue Energy Limited (ASX:BLU) releases Q4 2024 report highlighting ongoing production testing, financial stability, and progress in legal and exploration activities.
Dotz Nano Ltd (ASX:DTZ) secures its first US commercial order for DotzShield and receives a further A$2M investment to advance carbon capture technologies.
Vectus Biosystems Limited (ASX:VBS) releases its December 2024 Quarterly Activities Report, detailing clinical trial progress and a strong financial position.
Lincoln Minerals Limited (ASX:LML) announces December 2024 quarterly activities, focusing on project advancements and cost reduction strategies.
Andromeda Metals (ASX:ADN) reports Q4 progress on the Great White Project, highlighting funding advancements and government tax incentives.
Globe Metals & Mining (ASX:GBE) advances its Kanyika Niobium Project with $10 million funding from IDC and secures an additional $1.2 million loan.
Kula Gold (ASX:KGD) announces the results of its entitlement offer, issuing 66,441,764 new shares and outlining future share issuance plans.
Australian Pacific Coal Limited (ASX:AQC) reports first commercial coal rail, production ramp-up, and financing achievements in Q4 2024 activities report.
Peninsula Energy Limited (ASX:PEN) restarts Lance uranium production and appoints a new CEO, strengthening its position as an independent uranium producer.